skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi,

I'm not sure what to make of the announcement of QUIS hiring an outside company (Gateway) to help them with investor relations. Is it positive because Gateway will be able to increase QUIS visibility to institutional investors? Is it negative in that QUIS may be desperate and needs assistance? ...or is it a non-issue?

Thanks as always for your valuable insight.
Read Answer Asked by Brad on September 15, 2020
Q: As per my portfolio analysis I have reduced my position in tech and industrial. One area Where I don’t have an investment I.e. communication services I’ve taken A partial position in BCE. I need to add health care. What is your opinion of the above? What would be your top pick in this area.
Read Answer Asked by Roy on September 15, 2020
Q: I would appreciate your overview of the acquisition by Cloud MD of iMD Health Global Corp announced this morning. Is there a chance that CloudMD and Well might merge at some point in the future?
Thanks
Read Answer Asked by Gordon on September 15, 2020
Q: Hi 5i team,
Could you please recommend ETFs that invest primarily in US small/mid cap biotech, medical equipment/pharma and digital/IT companies? Thanks.
Read Answer Asked by Willie on September 14, 2020
Q: Could you please comment on their recent financing. One of their Intended use of financing funds seemed to be to repurchase their own shares? Selling shares to buy their own shares doesn’t seem to make sense unless they had plan to Drive the share Price down.
Do you think they are planning a big buy Or a series of acquisitions like their Sister company Phm.
What is your going forward perspective on vmd. They seem to be in an ideal market area (ventilators) and able or pull in funds very cheaply and their shares seem to have consolidated. Thank you for the great unbiased advice you provide us diy investors.
Read Answer Asked by mike on September 10, 2020
Q: NTAR: Can I please have your analysis on this company for 3 to 5 years hold.

Thanks in advance
Atchuta
Read Answer Asked by Atchuta on September 09, 2020
Q: Hi 5i,
Somehow I let myself get seduced by Corus and bought in some time ago, and I'm now sitting on a fairly large (but so far unrealized) loss in a registered account. I've kept thinking there's potential and I'll at least get to the point where I'm only down 50% and will unload then, but things only seem to get worse. So my questions:
Now that it's so cheap is there any reasonable prospect that Corus might be seen as worthwhile takeover target by anyone out there such that the stock could possibly get a bump, or should I just put that thought down to wishful thinking, take my lumps and put what (little) money I'll get from selling into something with better prospects?
And who might such a white knight be, if you think there could be one?
Thanks,
Peter
Read Answer Asked by Peter on September 08, 2020
Q: Hey Peter & Team,

Thanks for all your help this year and last. My subscription paid for itself in a matter of weeks. (please don't increase the price)
Having said that and before I proceed NO, I am not one of those "OH MY GOD, THE SKY IS FALLING" people at the first hint of a drop. I did however take on a new position in PHO on Wednesday and as of Friday's close it is off 13.9%.
Among my many rules, one in particular states "drop an equity when it gets to 15% below my average cost." A rule which allows me to avoid getting to that position where I wait, it goes down further then I get to the "have nothing to loose mentality" and end up with a name in my portfolio with a -88% in red next to it.
So... what do I do with PHO? I know you have been recommending it as one of a few equities to be added to a growth portfolio.
Do you see any reasons/trouble that might have caused the significant drop? Should I stick with my 15% rule. (hard to answer I know as it is a personal preference) Has your long term outlook for PHO changed? Is there any news you may have seen which could explain this precipitous drop? Feel free to add anything else.
Thanks for all you do

gm
Read Answer Asked by Gord on September 08, 2020
Q: Hello. I didn't find any questions asked about VERY. Would you be able to give me your thoughts about whether it might be worthy company to invest in? Thanks.
Read Answer Asked by Mary on September 08, 2020
Q: Could you give your thoughts on CGY? It seems to have done well through and after March (ie the COVID market drop) and as a concept, I like its multiple segments that might sustain the company in various markets. But my concern is the very breath in diversity of its segments, and how the company can continue to retain focus for operations as a small cap name and also clarity for investors. Thoughts? Thanks for your valued input.
Read Answer Asked by David C. on September 08, 2020
Q: Both NAVI and COOP look oddly undervalued even after one factors in known problems in their business models. NAVI pays a good dividend (too good?). COOP pays none. Is NAVI’s dividend well covered? COOP appears to trade at below book or is that incorrect? What do you calculate are the PEG ratios for each of theses companies? Financial sites give differing ratios.
What do you see as vulnerabilities that are perhaps not discernible to a non-finance professional? Interest rates are likely to remain low for several years; it appears the US economy will continue to be bolstered by at least some stimulus, however modest, through to at least end of year 2021. Would either company be a probable target by a new US Admin? I would be thankful for your looking under the hood. I am concerned there might be dangers of the type that are sometimes skipped even by premium finance sites.
Would you buy either company, and if yes, your preference (if any?)
Read Answer Asked by Adam on September 03, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!